10X Genomics Inc Class A (TXG)
R&D to Revenue
37.60%
Quarterly · Period ending:
TXG R&D to Revenue
Latest reported37.60%period ending
Latest reported37.60%period ending
TXG Quarterly R&D/Revenue (50.00% → 37.60%)
Latest values, visible window
High-resolution chart · PNG
TXG r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 37.601% | |
| 37.6862% | |
| 33.7102% | |
| 38.3847% | |
| 35.4084% | |
| 41.4797% | |
| 40.5815% | |
| 43.6349% | |
| 41.0949% | |
| 48.6774% | |
| 35.4752% | |
| 70.2331% | |
| 48.6722% | |
| 49.9669% | |
| 40.7177% | |
| 51.3382% | |
| 61.6749% | |
| 55.9653% | |
| 43.1164% | |
| 43.5621% | |
| 46.099% | |
| 39.5791% | |
| 35.382% | |
| 41.972% | |
| 64.1767% | |
| 36.1477% | |
| 37.0426% | |
| 36.2851% | |
| 32.308% | |
| 27.9312% | |
| 25.8733% | |
| 30.2811% | |
| 36.0509% | |
| 50.0034% |